Christopher S Fox

US Patent:

6714215, Mar 30, 2004

Filed:

May 19, 2000

Appl. No.:

09/574375

Inventors:

William T. Flora - Seattle WA
Robert Edward Parkin - Redmond WA
Christopher R. Fox - Seattle WA
Gregory R. Slayden - Kirkland WA

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 314

US Classification:

345716, 345859, 345862, 345838, 7155011

Abstract:

A graphical user interface (GUI) allows a user to directly access items of visual and/or audio media by passing a cursor over points on an electronic map. Indicators in the form of icons representing media items can be displayed and can be accessed through a media viewer. A determination is made whether a position indicator or pointer, such as a cursor, is located proximate to a GUI location that is associated with supplemental content in the form of a media item. If so, an indicator is presented to advise the user that supplemental content is indeed associated with that location on the interface. For example, a media icon representing one or more media items can be displayed on the output device proximate to the location of the input device indicator. This indicator serves as a prompt or cue for the user to select the indicator if the user desires to review the supplemental content. A determination is made whether the media icon has been selected in response to an input signal issued by an input device.

US Patent:

7805375, Sep 28, 2010

Filed:

Dec 21, 2005

Appl. No.:

11/316509

Inventors:

Christopher J. Fox - Woodinville WA, US
Clifford P. Strom - Sammamish WA, US
Matthew J. Bordenet - Sammamish WA, US
Michael Y. Siu - Bellevue WA, US
Stephen P. DiAcetis - Duvall WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 21/00

US Classification:

705 59, 705 56

Abstract:

A digital license is migrated from a source platform to a target platform. At the source platform, a migration image is produced to include the license and corresponding data therein, and the license is deleted from such source platform. At the target platform, permission is requested from a centralized migration service to migrate the license in the migration image to the target platform. The migration service determines whether to permit migration of the license based on predetermined migration policy. Upon receiving the requested permission as a response from the migration service, the migration image is applied to the target platform by un-tying the license from the source platform and re-tying the license to the target platform.

US Patent:

20060089917, Apr 27, 2006

Filed:

Oct 22, 2004

Appl. No.:

10/971346

Inventors:

Clifford Strom - Sammamish WA, US
Benjamin Cutter - Kirkland WA, US
Brian Evans - Redmond WA, US
Christopher Fox - Woodinville WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06Q 99/00
H04L 9/00
H04K 1/00

US Classification:

705059000

Abstract:

A method of synchronizing. A method of synchronizing comprising, transferring at least one license of a plurality of licenses from a first PC, populating a license store on a CE device with the at least one license of the plurality of licenses from the first PC, populating a synchronization list with all licenses having state, filtering the synchronization list according to at least one threshold value to create a filtered synchronization list of licenses to be refreshed and refreshing the licenses to be refreshed.

US Patent:

20220280640, Sep 8, 2022

Filed:

Apr 28, 2022

Appl. No.:

17/731671

Inventors:

- Seattle WA, US
Christopher B. FOX - Sumner WA, US

International Classification:

A61K 39/39
A61K 35/76
A61K 39/04
A61K 39/12
A61K 45/06
A61P 31/06
A61P 31/12
A61P 33/04
A61P 35/00
C07K 14/705

Abstract:

Stable aqueous formulations of adjuvant comprising a TLR7/8 agonist or a TLR4 agonist with a helper lipid that are adsorbed to alum are provided. Compositions and methods of using the formulations for stimulating an immune response are also provided.

US Patent:

20220257754, Aug 18, 2022

Filed:

Apr 28, 2022

Appl. No.:

17/731718

Inventors:

- Seattle WA, US
Christopher B. FOX - Sumner WA, US

International Classification:

A61K 39/39
A61K 39/04
A61K 39/12
C07K 14/705
A61K 35/76
A61K 45/06
A61P 31/12
A61P 33/04
A61P 31/06
A61P 35/00

Abstract:

Stable aqueous formulations of adjuvant comprising a TLR7/8 agonist or a TLR4 agonist with a helper lipid that are adsorbed to alum are provided. Compositions and methods of using the formulations for stimulating an immune response are also provided.

US Patent:

20220249646, Aug 11, 2022

Filed:

May 26, 2020

Appl. No.:

17/612893

Inventors:

- SEATTLE WA, US
Michelle ARCHER - Seattle WA, US
Christopher FOX - Sumner WA, US
Reinhard VEHRING - Edmonton, CA
Mani ORDOUBADI - Edmonton, CA
Mellissa GOMEZ - Leduc, CA
Nicholas CARRIGY - Sherwood Park, CA

International Classification:

A61K 39/04
A61K 39/39
A61K 9/00
A61K 31/7016
A61K 47/44
A61P 11/00

Abstract:

The invention provides for thermostable spray dried formulations including vaccines and pharmaceutical compositions for inducing or enhancing an immune response and methods of use thereof. The spray dried formulations are a dry powder generally comprising an antigen and/or an adjuvant, a metabolizable oil, and one or more excipients.

US Patent:

20200110046, Apr 9, 2020

Filed:

Oct 4, 2019

Appl. No.:

16/593145

Inventors:

- Baltimore MD, US
- Seattle WA, US
Christopher FOX - Sumner WA, US

International Classification:

G01N 24/08
G01N 33/15

Abstract:

A method of using the transverse relaxation rate (R) of solvent NMR signal to noninvasively assess alum-containing products such as vaccines. This technique can be used for quality control in vaccine manufacturing (e.g., fill-finish step) to determine the evenness of alum filling level as well as extent of alum particle sedimentation in filled and sealed products.

US Patent:

20200085757, Mar 19, 2020

Filed:

May 17, 2017

Appl. No.:

16/098617

Inventors:

- Seattle WA, US
Traci Mikasa - Seattle WA, US
Christopher B. Fox - Sumner WA, US
Anwar Ahniyaz - Stockholm, SE
Mark T. Orr - Seattle WA, US
Amit Khandhar - Redmond WA, US

Assignee:

Infectious Disease Research Institute - Seattle WA

International Classification:

A61K 9/51
A61K 9/127
A61K 39/39

Abstract:

Provided herein are nanoalum particles comprising an aluminum salt and a sizing agent, wherein the size of the particle N ranges from about 1 nm to 450 nm. Such nanoalum particles are stable and are amenable to a terminal sterilization step prior to vialing. Compositions comprising the nanoalum particles, and the making and using of the nanoalum particles are also provided.

Address:

5921 Cozumel Pl, Las Vegas, NV 89131

VIN:

1FAFP24107G105374

Make:

FORD

Model:

FIVE

Year:

2007